TABLE 1.

Increased detection of VT carriage by the microarray versus latex agglutination^a

Group	Latex agglutination		Microarray		% increase in VT prevalence
	No. of samples	VT prevalence (%) (95% CI)	No. of samples	VT prevalence (%) (95% CI)
Children
3–6 yr old, PCV vaccinated (n = 1,360)	272	20.0 (17.9, 22.2)	389	28.6 (26.2, 31.1)	43.0
5–10 yr old, not PCV vaccinated (n = 904)	191	21.1 (18.5, 23.9)	240	26.5 (23.7, 29.6)	21.7
Adults, 18–40 yr old, HIV infected, not PCV vaccinated (n = 963)	137	14.2 (12.1, 16.6)	160	16.6 (14.3, 19.1)	10.8
Total (n = 3,227)	600	18.6 (17.3, 20.0)	789	24.4 (23.0, 26.0)	31.5

^aVT, vaccine serotype; CI, confidence interval; PCV, pneumococcal conjugate vaccine.